Barnes Alane P

Avg. Two Year Performance

No purchase track record

24% Avg. Sale Return

11% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	6%	6%	9%	16%	24%
Sale Success Rate	3 of 6	3 of 6	2 of 6	3 of 6	3 of 6

BioCryst Pharmaceuticals Inc.

Drugs » Biotechnology

Chief Legal Officer:

Holdings: 300.76K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--